STAT3 and acute myeloid leukemia: ART reverses the resistance of AML cells to AraC by blocking the JAK/STAT3 signaling pathway, and the combination of ART and cytarabine significantly reduced the proliferation of AML cells and increased its apoptosis rate (Su et al., 2023).